Rottenstein Law Group Encouraged by $285,000 Fosamax Lawsuit Verdict in New York The Rottenstein Law Group, which accepts clients who wish to file Fosamax injury lawsuits, is encouraged by the Feb. 5 report of a $285,000 verdict against Merck in a New York trial over the drug Fosamax, which has been found to weaken bones and cause jaw death. (PRWeb February 05, 2013) Read the full story at http://www.prweb.com/releases/fosamax-side-effects/fosamax-lawsuit/prweb10400849.htm [News Source]